Unraveling the pathophysioiogy of IgE-mediated allergic disorders requires a thorough understanding of the complex mechanisms that control IgE antibody synthesis. The selective activation and further maturation of the IgE B cell are regulated by both antigen-specific and non-antigen-specific, but isotype-restricted, T cells and the soluble factors that they produce (1-6). Although the manner by which antigen-specific and isotype-restricted regulatory events are coordinated is still unresolved, studies of Ishizaka and colleagues (7-13) and of our group (14-19) indicate that the Fc determinants of IgE and the correspondingly specific Fc receptors for IgE (FcR~) ~ on lymphocytes contribute significantly to such regulatory mechanisms.IgE antibody responses can be significantly enhanced in experimental animals in which sensitization with antigen has been properly correlated with nonspecific perturbations such as low dose irradiation or treatment with immunosuppressive drugs (13,(20)(21)(22)(23). Similar perturbations, perhaps resulting from common respiratory virus infections (15), could be responsible for development of high IgE responses in individuals exposed to allergens over a sustained period of time (21), and are probably involved in the enhanced IgE production that accompanies parasite infections (22). Certain of the experimentally induced perturbations in normal mechanisms controlling IgE antibody responses can be selectively reversed by in vivo administration of biologically active soluble factors, obtained from body fluids of living animals (23). This is publication number 34 from the